These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11519128)

  • 41. The dominant roles of ICAM-1-encoding gene in DNA vaccination against Japanese encephalitis virus are the activation of dendritic cells and enhancement of cellular immunity.
    Zhai YZ; Zhou Y; Ma L; Feng GH
    Cell Immunol; 2013 Jan; 281(1):1-10. PubMed ID: 23411485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
    Wild J; Grusby MJ; Schirmbeck R; Reimann J
    J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.
    Ishioka GY; Fikes J; Hermanson G; Livingston B; Crimi C; Qin M; del Guercio MF; Oseroff C; Dahlberg C; Alexander J; Chesnut RW; Sette A
    J Immunol; 1999 Apr; 162(7):3915-25. PubMed ID: 10201910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses.
    Johnson PA; Conway MA; Daly J; Nicolson C; Robertson J; Mills KH
    J Gen Virol; 2000 Jul; 81(Pt 7):1737-45. PubMed ID: 10859379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Response of human monocyte-derived dendritic cells to immunostimulatory DNA.
    Schattenberg D; Schott M; Reindl G; Krueger T; Tschoepe D; Feldkamp J; Scherbaum WA; Seissler J
    Eur J Immunol; 2000 Oct; 30(10):2824-31. PubMed ID: 11069063
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunology of DNA vaccines: CpG motifs and antigen presentation.
    Manders P; Thomas R
    Inflamm Res; 2000 May; 49(5):199-205. PubMed ID: 10893042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun.
    Fensterle J; Grode L; Hess J; Kaufmann SH
    J Immunol; 1999 Oct; 163(8):4510-8. PubMed ID: 10510394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
    Marsac D; Puaux AL; Rivière Y; Michel ML
    Immunobiology; 2005; 210(5):305-19. PubMed ID: 16164038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines.
    Colluru VT; McNeel DG
    Oncotarget; 2016 Oct; 7(42):67901-67918. PubMed ID: 27661128
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells.
    Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D
    J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens.
    Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
    Immunology; 2006 Mar; 117(3):419-30. PubMed ID: 16476062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L; Anand KK; Mohankumar KM; Ranga U
    J Virol; 2004 Sep; 78(17):9174-89. PubMed ID: 15308713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
    Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
    Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine.
    Roos AK; Pavlenko M; Charo J; Egevad L; Pisa P
    Prostate; 2005 Feb; 62(3):217-23. PubMed ID: 15389792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization.
    Sato Y; Roman M; Tighe H; Lee D; Corr M; Nguyen MD; Silverman GJ; Lotz M; Carson DA; Raz E
    Science; 1996 Jul; 273(5273):352-4. PubMed ID: 8662521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Particle-mediated DNA vaccine delivery to the skin.
    Haynes JR
    Expert Opin Biol Ther; 2004 Jun; 4(6):889-900. PubMed ID: 15174971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasmid DNA expression systems for the purpose of immunization.
    Davis HL
    Curr Opin Biotechnol; 1997 Oct; 8(5):635-46. PubMed ID: 9353234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineered Nanodelivery Systems to Improve DNA Vaccine Technologies.
    Lim M; Badruddoza AZM; Firdous J; Azad M; Mannan A; Al-Hilal TA; Cho CS; Islam MA
    Pharmaceutics; 2020 Jan; 12(1):. PubMed ID: 31906277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.